Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 25, 2013, Pages 10306-10311

  Yang, Guang ^a,b   Parkhurst, Christopher N ^a   Hayes, Scott ^a,b   Gan, Wen Biao ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC SPINE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MICROSCOPY; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSENSORY CORTEX; SYNAPSE; T LYMPHOCYTE; TWO PHOTON MICROSCOPY;

ANIMALS; AXONS; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SCLEROSIS; PARALYSIS; PRESYNAPTIC TERMINALS; SOMATOSENSORY CORTEX; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84879294268     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222895110     Document Type: Article

References (64)

1. Lisak RP (2007) Neurodegeneration in multiple sclerosis: Defining the problem. Neurology 68(22 Suppl 3):S5-S12; discussion S43-S54.
2. Magnano I, Aiello I, Piras MR (2006) Cognitive impairment and neurophysiological correlates in MS. J Neurol Sci 245(1-2):117-122.
3. Mayeux R, Benson DF (1979) Phantom limb and multiple sclerosis. Neurology 29(5):724-726.
4. Zarei M, Chandran S, Compston A, Hodges J (2003) Cognitive presentation of multiple sclerosis: Evidence for a cortical variant. J Neurol Neurosurg Psychiatry 74(7):872-877.
5. Achiron A, Barak Y (2003) Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74(4):443-446.
6. Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: An overview. Brain Pathol 17(2):210-218.
7. Wensky AK, et al. (2005) IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. J Immunol 174(3):1416-1423.
8. Centonze D, et al. (2010) The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 17(7):1083-1091.
9. Hofstetter HH, et al. (2005) The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice. J Neuroimmunol 170(1-2):105-114.
10. Brambilla R, et al. (2011) Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination.. Brain 134(Pt 9):2736-2754.
11. Baune BT, et al. (2012) Tumour necrosis factor-alpha mediated mechanisms of cognitive dysfunction. Transl Neurosci 3(3):263-277.
12. Gendron RL, Nestel FP, Lapp WS, Baines MG (1991) Expression of tumor necrosis factor alpha in the developing nervous system. Int J Neurosci 60(1-2):129-136.
13. Kaneko M, Stellwagen D, Malenka RC, Stryker MP (2008) Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron 58(5):673-680.
14. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for proinflammatory cytokines in regulating synaptic plasticity in major depressive disorder.. Int J Neuropsychopharmacol 12(4):561-578.
15. Leonoudakis D, Braithwaite SP, Beattie MS, Beattie EC (2004) TNFalpha-induced AMPA-receptor trafficking in CNS neurons: Relevance to excitotoxicity? Neuron Glia Biol 1(3):263-273.
16. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease.. J Neuroinflammation 5(1):45.
17. Reichenberg A, et al. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58(5):445-452.
18. Sriram K, O'Callaghan JP (2007) Divergent roles for tumor necrosis factor-α in the brain. J Neuroimmune Pharmacol 2(2):140-153.
19. Centonze D, et al. (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.. J Neurosci 29(11):3442-3452.
20. Javed A, Arnason B G W (2009) Demyelinating diseases. Encyclopedia of Neuroscience, ed Larry RS (Academic Press, New York), pp 415-422.
21. Peruga I, et al. (2011) Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav Brain Res 220(1):20-29.
22. Ransohoff RM, Kivisäkk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3(7):569-581.
23. Kim JV, et al. (2010) Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites.. J Immunol Methods 352(1-2):89-100.
24. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28(2):254-260.
25. Pollak Y, Ovadia H, Orion E, Weidenfeld J, Yirmiya R (2003) The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J Neuroimmunol 137(1-2):94-99.
26. Gutierrez EG, Banks WA, Kastin AJ (1993) Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 47(2):169-176.
27. Pan WH, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ (1996) Differential permeability of the BBB in acute EAE: Enhanced transport of TNF-alpha. Am J Physiol-Endoc M 271(4):E636-E642.
28. Pan W, Kastin AJ (2002) TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 174(2):193-200.
29. Boettger MK, Weishaupt A, Geis C, Toyka KV, Sommer C (2010) Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction. J Neural Transm 117(2):165-169.
30. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087):1054-1059.
31. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha.. J Neurosci 25(12):3219-3228.
32. Beattie EC, et al. (2002) Control of synaptic strength by glial TNFalpha. Science 295(5563):2282-2285.
33. Baker D, et al. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins.. Eur J Immunol 24(9):2040-2048.
34. Probert L, et al. (2000) TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.. Brain 123(Pt 10):2005-2019.
35. Zalevsky J, et al. (2007) Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection.. J Immunol 179(3):1872-1883.
36. Steed PM, et al. (2003) Inactivation of TNF signaling by rationally designed dominantnegative TNF variants. Science 301(5641):1895-1898.
37. Grutzendler J, Kasthuri N, Gan WB (2002) Long-term dendritic spine stability in the adult cortex. Nature 420(6917):812-816.
38. Yang G, Pan F, Parkhurst CN, Grutzendler J, Gan WB (2010) Thinned-skull cranial window technique for long-term imaging of the cortex in live mice. Nat Protoc 5(2):201-208.
39. Yang G, Pan F, Gan WB (2009) Stably maintained dendritic spines are associated with lifelong memories. Nature 462(7275):920-924.
40. Shepherd GM, Harris KM (1998) Three-dimensional structure and composition of CA3→CA1 axons in rat hippocampal slices: Implications for presynaptic connectivity and compartmentalization.. J Neurosci 18(20):8300-8310.
41. Brown DA, Sawchenko PE (2007) Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.. J Comp Neurol 502(2):236-260.
42. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9(6):393-407.
43. Lichtman JW, Colman H (2000) Synapse elimination and indelible memory. Neuron 25(2):269-278.
44. Bailey CH, Kandel ER (1993) Structural changes accompanying memory storage. Annu Rev Physiol 55:397-426.
45. Staffen W, et al. (2002) Cognitive function and fMRI in patients with multiple sclerosis: Evidence for compensatory cortical activation during an attention task.. Brain 125(Pt 6):1275-1282.
46. Bø L, Vedeler CA, Nyland H, Trapp BD, Mørk SJ (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9(4):323-331.
47. Gutierrez H, Davies AM (2011) Regulation of neural process growth, elaboration and structural plasticity by NF-κB. Trends Neurosci 34(6):316-325.
48. Saha RN, Liu X, Pahan K (2006) Up-regulation of BDNF in astrocytes by TNF-alpha: A case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 1(3):212-222.
49. Horch HW, Krüttgen A, Portbury SD, Katz LC (1999) Destabilization of cortical dendrites and spines by BDNF. Neuron 23(2):353-364.
50. Aloe L, et al. (1999) Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice, one characterized by neurological disorders, the other phenotypically normal. Brain Res 840(1):125-137.
51. Kerschensteiner M, Meinl E, Hohlfeld R (2009) Neuro-immune crosstalk in CNS diseases. Neuroscience 158(3):1122-1132.
52. Bartholomäus I, et al. (2009) Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462(7269):94-98.
53. Gimenez MA, Sim JE, Russell JH (2004) TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J Neuroimmunol 151(1-2):116-125.
54. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732-741.
55. Stigler KA, Sweeten TL, Posey DJ, McDougle CJ (2009) Autism and immune factors: A comprehensive review. Res Autism Spectr Disord 3(4):840-860.
56. Di Filippo M, Sarchielli P, Picconi B, Calabresi P (2008) Neuroinflammation and synaptic plasticity: Theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29(8):402-412.
57. Terrando N, et al. (2010) Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA 107(47):20518-20522.
58. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39(1):51-68.
59. Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD (2008) Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.. Biol Psychiatry 63(11):1022-1029.
60. Lim SY, Constantinescu CS (2010) TNF-α: A paradigm of paradox and complexity in multiple sclerosis and its animal models. Open Autoimmun J 2:160-170.
61. Gregory AP, et al. (2012) TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488(7412):508-511.
62. Belarbi K, et al. (2012) TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.. J Neuroinflammation 9:23.
63. Raison CL, et al. (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers.. JAMA Psychiatry 70(1):31-41.
64. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA, Jr. (1993) Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.. J Exp Med 177(1):57-68.